生物标志物 生物标志物
Hongming Zhang1, Jingwen Eh Tan2, Nan Zhang2
1Frontage Laboratories, Exton, PA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
血pTau217测定显示出早期阿尔茨海默病诊断的前景. 对七个平台进行了对比,发现了独特的优势,有助于临床研究和诊断应用选择.
科学领域:
- 生物标志物发现和验证
- 神经退行性疾病的诊断 神经退行性疾病的诊断
- 临床免疫测试的发展
背景情况:
- 血pTau217是早期发现阿尔茨海默病 (AD) 的关键血液生物标志物,可以在症状出现前几十年预测发病.
- 现有大量的pTau217试验,需要对临床实用性进行平台比较.
- 这项研究比较了在临床试验和LDT中使用的七个pTau217免疫测试平台.
研究的目的:
- 为了进行七个不同的血pTau217免疫测试平台的对比比较.
- 评估每个阿尔茨海默病诊断平台的性能特征.
- 为选择适合临床研究和LDT应用的平台提供指导.
主要方法:
- 在各自的制造商平台上测试了七种等离子pTau217测试:贝克曼Coulter DxI 9000,富吉雷比奥Lumipulse G1200,AstrBio Ast-Sc-Semi,Quanterix Simoa HD-X,MSD Sector S600,Sigma SMCxPRO,以及Alamar ARGO HT.
- 测试是按照制造商的指示进行的.
- 性能通过多个参数进行评估,包括准确性,精度,灵敏度,吞吐量和成本.
主要成果:
- 所有七个测试的pTau217测试都在各自的平台上表现良好.
- 每个平台都展示了与血pTau217分析相关的独特特征.
- 评估的关键性能指标包括硬件,软件,样品准备,自动化,运行时间,准确性,精度,检测范围,灵敏度,相关性,成本和维护.
结论:
- 七个评估的pTau217测定为血分析提供了明显的优势.
- 这些发现为选择临床研究和LDT诊断应用平台提供了宝贵的参考.
- 这种比较有助于优化早期阿尔茨海默病检测策略.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516